• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Treatment of severe psoriasis with infliximab.英夫利昔单抗治疗重度银屑病。
Ther Clin Risk Manag. 2008 Dec;4(6):1165-76. doi: 10.2147/tcrm.s3094.
2
Inflammation in atherosclerosis and psoriasis: common pathogenic mechanisms and the potential for an integrated treatment approach.动脉粥样硬化与银屑病中的炎症:共同致病机制及综合治疗方法的潜力
Br J Dermatol. 2008 Aug;159 Suppl 2:10-7. doi: 10.1111/j.1365-2133.2008.08780.x.
3
[Treatment of psoriasis using biologics].
Nihon Rinsho Meneki Gakkai Kaishi. 2010;33(3):126-34. doi: 10.2177/jsci.33.126.
4
Psoriasis and its treatment with infliximab-mediated tumor necrosis factor alpha blockade.银屑病及其通过英夫利昔单抗介导的肿瘤坏死因子α阻断治疗。
Dermatol Clin. 2004 Oct;22(4):437-47, ix. doi: 10.1016/j.det.2004.03.011.
5
Treatment of psoriasis and psoriatic arthritis.治疗银屑病和银屑病关节炎。
BioDrugs. 2013 Jan;27 Suppl 1:3-12. doi: 10.1007/BF03325637.
6
Infliximab in psoriasis and psoriatic arthritis.英夫利昔单抗治疗银屑病和银屑病关节炎。
BioDrugs. 2013 Jan;27 Suppl 1:13-23. doi: 10.1007/BF03325638.
7
Biologic therapies in psoriasis: a new therapeutic approach.银屑病的生物疗法:一种新的治疗方法。
Autoimmun Rev. 2007 Sep;6(8):515-9. doi: 10.1016/j.autrev.2006.12.002. Epub 2007 Jan 9.
8
Infliximab for the treatment of psoriasis.英夫利昔单抗用于治疗银屑病。
Expert Opin Biol Ther. 2006 Aug;6(8):797-805. doi: 10.1517/14712598.6.8.797.
9
Infliximab in the treatment of plaque type psoriasis.英夫利昔单抗治疗斑块状银屑病。
Clin Cosmet Investig Dermatol. 2009 Apr 3;2:27-37. doi: 10.2147/ccid.s3413.
10
Infliximab for severe, treatment-resistant psoriasis: a prospective, open-label study.英夫利昔单抗治疗重度、难治性银屑病:一项前瞻性、开放标签研究。
Br J Dermatol. 2006 Jul;155(1):160-9. doi: 10.1111/j.1365-2133.2006.07316.x.

引用本文的文献

1
Psoriasis Treatments: Emerging Roles and Future Prospects of MicroRNAs.银屑病治疗:微小RNA的新作用与未来前景
Noncoding RNA. 2025 Feb 13;11(1):16. doi: 10.3390/ncrna11010016.
2
The Emerging Specialty of Cardio-Rheumatology.心血管风湿病学:新兴亚专科
Curr Atheroscler Rep. 2024 Sep;26(9):499-509. doi: 10.1007/s11883-024-01221-7. Epub 2024 Jun 24.
3
Effects of secukinumab and adalimumab on serum uric acid level in patients with plaque psoriasis.司库奇尤单抗和阿达木单抗对斑块状银屑病患者血尿酸水平的影响。
Chin Med J (Engl). 2022 Jun 20;135(12):1438-1443. doi: 10.1097/CM9.0000000000002130.
4
Adherence and Persistence to Biological Drugs for Psoriasis: Systematic Review with Meta-Analysis.银屑病生物制剂的依从性和持续性:系统评价与荟萃分析
J Clin Med. 2022 Mar 9;11(6):1506. doi: 10.3390/jcm11061506.
5
Burden of Moderate-to-Severe Plaque Psoriasis and New Therapeutic Approaches (Secukinumab): An Italian Perspective.中重度斑块状银屑病的负担与新治疗方法(司库奇尤单抗):意大利视角
Dermatol Ther (Heidelb). 2016 Jun;6(2):151-67. doi: 10.1007/s13555-016-0114-9. Epub 2016 Apr 15.
6
The safety of infliximab infusions in the community setting.英夫利昔单抗在社区环境中输注的安全性。
Can J Gastroenterol. 2010 May;24(5):307-11. doi: 10.1155/2010/138456.

本文引用的文献

1
Long-term management of generalized pustular psoriasis with infliximab: case series.英夫利昔单抗治疗泛发性脓疱型银屑病的长期管理:病例系列
J Cutan Med Surg. 2008 Jul-Aug;12(4):184-8. doi: 10.2310/7750.2008.07036.
2
Review and expert opinion on prevention and treatment of infliximab-related infusion reactions.英夫利昔单抗相关输注反应防治的综述与专家意见
Br J Dermatol. 2008 Sep;159(3):527-36. doi: 10.1111/j.1365-2133.2008.08728.x. Epub 2008 Jul 9.
3
Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: a literature review and potential mechanisms of action.肿瘤坏死因子拮抗剂治疗诱发的银屑病皮肤病变:文献综述及潜在作用机制
Arthritis Rheum. 2008 Jul 15;59(7):996-1001. doi: 10.1002/art.23835.
4
Evaluation of the efficacy and safety of infliximab on psoriatic nails: an unblinded, nonrandomized, open-label study.英夫利昔单抗治疗银屑病甲的疗效和安全性评估:一项非盲、非随机、开放标签研究。
Br J Dermatol. 2008 Aug;159(2):453-6. doi: 10.1111/j.1365-2133.2008.08686.x. Epub 2008 Jun 28.
5
Manifestation of palmoplantar pustulosis during or after infliximab therapy for plaque-type psoriasis: report on five cases.英夫利昔单抗治疗斑块型银屑病期间或之后掌跖脓疱病的表现:5例报告
Arch Dermatol Res. 2008 Mar;300(3):101-5. doi: 10.1007/s00403-008-0831-8. Epub 2008 Feb 1.
6
Tumor necrosis factor-alpha inhibitor-induced psoriasis or psoriasiform exanthemata: first 120 cases from the literature including a series of six new patients.肿瘤坏死因子-α抑制剂诱发的银屑病或银屑病样疹:来自文献的首批120例病例,包括6例新患者系列。
Am J Clin Dermatol. 2008;9(1):1-14. doi: 10.2165/00128071-200809010-00001.
7
Infliximab in recalcitrant generalized pustular arthropatic psoriasis.英夫利昔单抗治疗顽固性泛发性脓疱型关节病性银屑病
Eur J Dermatol. 2008 Jan-Feb;18(1):71-3. doi: 10.1684/ejd.2008.0314. Epub 2007 Dec 18.
8
Baseline nail disease in patients with moderate to severe psoriasis and response to treatment with infliximab during 1 year.中度至重度银屑病患者的基线指甲疾病及英夫利昔单抗治疗1年的反应
J Am Acad Dermatol. 2008 Feb;58(2):224-31. doi: 10.1016/j.jaad.2007.07.042. Epub 2007 Dec 20.
9
Brief communication: characteristics of spontaneous cases of tuberculosis associated with infliximab.简短通讯:英夫利昔单抗相关结核病自发病例的特征
Ann Intern Med. 2007 Nov 20;147(10):699-702. doi: 10.7326/0003-4819-147-10-200711200-00006.
10
Anti-tumour necrosis factor-alpha therapy increases body weight in patients with chronic plaque psoriasis: a retrospective cohort study.抗肿瘤坏死因子-α治疗可增加慢性斑块状银屑病患者的体重:一项回顾性队列研究。
J Eur Acad Dermatol Venereol. 2008 Mar;22(3):341-4. doi: 10.1111/j.1468-3083.2007.02429.x. Epub 2007 Nov 14.

英夫利昔单抗治疗重度银屑病。

Treatment of severe psoriasis with infliximab.

机构信息

Alan Lyell Centre for Dermatology, Western Infirmary, Glasgow, UK.

出版信息

Ther Clin Risk Manag. 2008 Dec;4(6):1165-76. doi: 10.2147/tcrm.s3094.

DOI:10.2147/tcrm.s3094
PMID:19337424
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2643098/
Abstract

Psoriasis is a chronic, immune mediated inflammatory disease characterized by increased cell signalling via cytokines and chemokines on a background of up-regulated gene expression. There is substantial evidence that psoriasis should be regarded as more than a cutaneous disease; major psychological morbidity and increased mortality from cardiovascular disease and cancer are increasingly recognized. Improved understanding of the genetic and immunological mechanisms underpinning psoriasis has occurred concurrently with the development of targeted biological therapies including infliximab. These newer therapeutic approaches can be very effective but their long term safety profile is not yet fully determined.

摘要

银屑病是一种慢性、免疫介导的炎症性疾病,其特征是细胞因子和趋化因子信号的增加,以及基因表达的上调。有大量证据表明,银屑病不仅仅是一种皮肤疾病;人们越来越认识到,它还会导致严重的心理障碍,以及心血管疾病和癌症死亡率的增加。随着针对生物疗法(包括英夫利昔单抗)的发展,人们对银屑病的遗传和免疫机制有了更深入的了解。这些新的治疗方法可能非常有效,但它们的长期安全性尚未完全确定。